Alzheimer’s Disease is the largest neurodegenerative disease opportunity, affecting over 5.4 million sufferers, 15 million unpaid caregivers and costing over $200 billion annually in the United States alone. Currently, there are no effective treatments for Alzheimer’s Disease on the market.


Alzheimer’s is deadly. 

Alzheimer’s is the 6th leading cause of death, and the only one in the top 10 that is rising. It is also the only one that cannot be prevented, cured or even slowed.


Alzheimer’s has an enormous social and economic burden. 

Alzheimer’s is the most expensive condition in the US, costing over $200 billion in direct costs annually. This is expected to increase to $1.2 trillion by 2050. There are more than 15.6 million unpaid caregivers in the US alone, representing more than $200 billion additional dollars of social burden.


Alzheimer’s affects primarily the elderly. 

The disease affects mostly seniors with 1 in 9 people age 65 and over, and 1 in 3 people age 85 and over. Approximately 200,000 individuals under age 65 have early-onset Alzheimer’s.